|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.075 AUD | 0.00% |
|
0.00% | +25.00% |
| Feb. 25 | Bio-Gene Technology Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
| Jan. 19 | Bio-gene Technology Secures R&D Tax Rebate for Fiscal Year 2023 | MT |
Bio-Gene Technology Limited reported earnings results for the half year ended December 31, 2023. For the half year, the company reported sales was AUD 0.018755 million. Net loss was AUD 1.51 million compared to AUD 1.97 million a year ago.
Basic loss per share from continuing operations was AUD 0.0084 compared to AUD 0.0117 a year ago. Diluted loss per share from continuing operations was AUD 0.0084 compared to AUD 0.0117 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +25.00% | 9.85M | |
| +14.61% | 38.38B | |
| -.--% | 11.15B | |
| -7.28% | 7.3B | |
| +7.47% | 6.87B | |
| -3.91% | 5.91B | |
| -10.44% | 5.6B | |
| -6.14% | 5.54B | |
| +31.35% | 5.19B | |
| -13.45% | 4.58B |
BIO-GENE TECHNOLOGY LIMITED 
